Bayforest Capital LTD Takeda Pharmaceutical CO LTD Transaction History
Bayforest Capital LTD
- $210 Billion
- Q3 2025
A detailed history of Bayforest Capital LTD transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Bayforest Capital LTD holds 19,754 shares of TAK stock, worth $282,284. This represents 0.14% of its overall portfolio holdings.
Number of Shares
19,754
Previous 16,005
23.42%
Holding current value
$282,284
Previous $247 Million
16.88%
% of portfolio
0.14%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding TAK
# of Institutions
382Shares Held
80.7MCall Options Held
1.67MPut Options Held
276K-
Capital Research Global Investors Los Angeles, CA13.4MShares$192 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.69MShares$110 Million0.01% of portfolio
-
Ubs Group Ag5.89MShares$84.2 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.95MShares$70.8 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.93MShares$56.2 Million0.48% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.4B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...